Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Chicago Recovery Alliance (CRA) is a prominent non-profit harm reduction organization that provides comprehensive healthcare services to people who use drugs. Established in 1992, the organization is widely recognized for pioneering the distribution of naloxone to prevent opioid overdose deaths and for operating extensive syringe exchange programs. CRA offers a variety of services including mobile outreach, HIV and Hepatitis C testing, wound care, and health education based on the "Any Positive Change" philosophy. Their mission focuses on reducing drug-related harm and improving the quality of life for marginalized populations through evidence-based public health strategies. The organization operates multiple mobile units across Chicago to reach high-need areas and provides peer-led support and advocacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chicago Recovery Alliance.